Join the club for FREE to access the whole archive and other member benefits.

Stephanie Manson-Brown

Head of Clinical Development, Vice President at R&D Allergan Aesthetics at AbbVie.

Dr Stephanie Manson Brown is an experienced leader in the biotech and pharmaceutical industry. Stephanie is a board-certified surgeon, specialised in plastic surgery. Currently, Stephanie leads the Clinical Development organisation at Allergan Aesthetics, an AbbVie company. She and her team are responsible for global clinical trial development strategy for the Aesthetics portfolio covering both pharmaceuticals and device.

Stephanie also has extensive experience in Medical Affairs and prior to her current role, led the Global Medical Affairs organisation for Aesthetics at Allergan. She has held multiple positions within Medical Affairs covering therapeutic areas including Aesthetic Medicine, Neurosciences, Urology, Psychiatry, Gastro-Intestinal, Cardiology, Hand Surgery & Diabetes, as well as supporting the UK Government Affairs team whilst at Pfizer. Prior to joining Allergan, Stephanie worked at Pfizer and Novo Nordisk.

Visit website:



See also: Company Allergan - Pharmaceutical company that acquires, develops, and markets brand name drugs.

Details last updated 25-Feb-2021

Stephanie Manson-Brown is also referenced in the following:

Harnessing the Biology of Ageing for Advanced Skincare and Aesthetics


Online webinar about biology of ageing, and how is it being applied in the beauty sector organized by LSX Leaders.

Healthspan Show

10-May-2021 to 14-May-2021

Online event about longevity and wellness organized by Longevity Leaders (LSX) with many speakers included.

Longevity Leaders World Congress 2021

04-May-2021 to 07-May-2021

The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).

Longevity Leaders World Congress 2022

26-Feb-2022 to 27-Feb-2022

Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)